AGO2 and hepatocellular carcinoma: The results indicated that CASC7 is a risk factor, and patients with high serum levels of CASC7 had a 1.358 times higher risk of developing HCC compared with patients with low serum levels (OR = 1.358, 95% CI: 1.159–1.591, p < 0.001).